General Information

All
  • All
  • Ongoing
  • Completed
Jan 20 @ 3:39 am

Pulmonary Function Study

This study seeks to establish the natural history of pulmonary function decline in the A-T population.

more
Jan 20 @ 3:39 am

Swallowing Study

Goals of this study are to develop non-invasive markers that will lessen the impact of swallowing dysfunction.

more
Jan 20 @ 3:39 am

IB1001 Trial

IntraBio, Inc. is studying the effects of N-Acetyl-L-Leucine on A-T.

more
Jan 20 @ 3:39 am

Machine Vision and Learning for A-T Neurophenotypes

This study seeks to develop sensitive, automated and objective means of measuring neurological disease severity.

more
Jan 20 @ 3:39 am

Global A-T Family Data Platform

The Platform is a patient-driven effort through which data about people with A-T are shared with researchers.

more
Jan 20 @ 3:39 am

NEAT

This trial will evaluate the effects of EryDex in patients with A-T.

more
Jan 20 @ 3:39 am

L-Dopa Treatment Trial

No overall consistent improvement in neurologic function was observed on L-Dopa.

more
Jan 20 @ 3:39 am

OxiDative Stress Clinical Trial

Two laboratory markers of oxidative stress improved when participants took both alpha-lipoic acid and nicotinamide.

more
Jan 20 @ 3:39 am

Cerebrospinal Fluid Biomarker Study

Among the 204 identified CSF proteins, 13 showed significant changes in A-T patients versus control samples.

more
Jan 20 @ 3:39 am

Effect of Amantadine on Movement Disorder in A-T

This trial was performed to see if amantadine sulphate improves ataxia or other movement disorders associated with A-T.

more
Jan 20 @ 3:39 am

Baclofen Study

At the dose tested, Baclofen did not have a significant effect on tremor, eye movement or balance deficits.

more
Jan 20 @ 3:39 am

ATTeST

This trial assessed the safety and efficacy of the EryDex System to treat neurological symptoms associated with A-T.

more